ALT
Price:
$2.61
Market Cap:
$230.35M
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted ...[Read more]
Industry
Biotechnology
IPO Date
2017-05-26
Stock Exchange
NASDAQ
Ticker
ALT
According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 29.56. This represents a change of 37.91% compared to the average of 21.43 of the last 4 quarters.
The mean historical Current Ratio of Altimmune, Inc. over the last ten years is 11.65. The current 29.56 Current Ratio has changed 25.27% with respect to the historical average. Over the past ten years (40 quarters), ALT's Current Ratio was at its highest in in the September 2016 quarter at 37.02. The Current Ratio was at its lowest in in the December 2016 quarter at 1.09.
Average
11.65
Median
11.24
Minimum
1.09
Maximum
19.16
Discovering the peaks and valleys of Altimmune, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 463.21%
Maximum Annual Current Ratio = 19.16
Minimum Annual Increase = -86.27%
Minimum Annual Current Ratio = 1.09
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 18.55 | 41.47% |
| 2024 | 13.11 | -24.05% |
| 2023 | 17.26 | 52.69% |
| 2022 | 11.31 | 1.23% |
| 2021 | 11.17 | -41.69% |
| 2020 | 19.16 | 90.75% |
| 2019 | 10.04 | 15.47% |
| 2018 | 8.70 | 42.30% |
| 2017 | 6.11 | 463.21% |
| 2016 | 1.09 | -86.27% |
The current Current Ratio of Altimmune, Inc. (ALT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.31
5-year avg
14.28
10-year avg
11.65
Altimmune, Inc.’s Current Ratio is greater than DBV Technologies S.A. (4.76), greater than Annexon, Inc. (6.35), greater than Korro Bio, Inc. (8.13), greater than enGene Holdings Inc. (11.75), greater than Larimar Therapeutics, Inc. (4.29), greater than Aura Biosciences, Inc. (7.09), greater than Amarin Corporation plc (3.48), greater than Alto Neuroscience, Inc. (20.52), less than LB Pharmaceuticals Inc Common Stock (35.68), greater than AC Immune S.A. (0.87),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.76 | $416.60M | |
| 6.35 | $563.29M | |
| 8.13 | $115.56M | |
| 11.75 | $82.94M | |
| 4.29 | $296.96M | |
| 7.09 | $411.52M | |
| 3.48 | $315.21M | |
| 20.52 | $753.47M | |
| 35.68 | $814.99M | |
| 0.87 | $235.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Altimmune, Inc.'s Current Ratio?
How is the Current Ratio calculated for Altimmune, Inc. (ALT)?
What is the highest Current Ratio for Altimmune, Inc. (ALT)?
What is the 3-year average Current Ratio for Altimmune, Inc. (ALT)?
What is the 5-year average Current Ratio for Altimmune, Inc. (ALT)?
How does the current Current Ratio for Altimmune, Inc. (ALT) compare to its historical average?